Library
On this page you can find relevant researchs on drug-related health topics, including HIV, hepatitis C, drug and overdose prevention, harm reduction and drug treatment. You can also find our Clinical Guidelines.
Needle syringe programmes and opioid substitution therapy for preventing HCV transmission among people who inject drugs: findings from a Cochrane Review and meta-analysis
To estimate the effects of needle syringe programmes (NSP) and opioid substitution therapy (OST), alone or in combination, for preventing acquisition of Hepatitis C virus (HCV) in people who inject drugs (PWID).
To estimate the effects of needle syringe programmes (NSP) and opioid substitution therapy (OST), alone or in combination, for preventing acquisition of Hepatitis C virus (HCV) in people who inject drugs (PWID).
Some People Still Need Opioids
The crackdown on pain medication prescribing is intended to help the addiction crisis—but it’s leaving chronic pain patients in untenable situations.
The crackdown on pain medication prescribing is intended to help the addiction crisis—but it’s leaving chronic pain patients in untenable situations.
European drug report 2017 and opioid-induced deaths
The EDR 2017 provides no evidence that there is a public health problem from the prescription of opioid analgesics to pain patients in the countries it covers.
The EDR 2017 provides no evidence that there is a public health problem from the prescription of opioid analgesics to pain patients in the countries it covers.
Stigma among health professionals towards patients with substance use disorders and its consequences for healthcare delivery
Healthcare professionals are crucial in the identification and accessibility to treatment for people with substance use disorders. Our objective was to assess health professionals’ attitudes towards patients with substance use disorders and examine the consequences of these attitudes on healthcare delivery for these patients in Western countries.
Healthcare professionals are crucial in the identification and accessibility to treatment for people with substance use disorders. Our objective was to assess health professionals’ attitudes towards patients with substance use disorders and examine the consequences of these attitudes on healthcare delivery for these patients in Western countries.
Decriminalize all drug possession? Not a bad idea: Editorial
NDP leadership Jagmeet Singh’s decriminalization proposal, while politically bold, reflects a view that is relatively uncontroversial among public health experts. (DARRYL DYCK / THE CANADIAN PRESS)
NDP leadership Jagmeet Singh’s decriminalization proposal, while politically bold, reflects a view that is relatively uncontroversial among public health experts. (DARRYL DYCK / THE CANADIAN PRESS)
Playing relationship counsellor – can we avert a divorce between scientific evidence and drug policy?
Nowhere is the divorce between rhetoric and reality more evident than in the formulation of global drug policies, where too often emotions and ideology rather than evidence have prevailed.
Nowhere is the divorce between rhetoric and reality more evident than in the formulation of global drug policies, where too often emotions and ideology rather than evidence have prevailed.
Reframing the War on Drugs – a Conversation with German Lopez
“In the middle of us continuing mass incarceration and a tough war on drugs we are having the worst drug epidemic in US history. If these policies actually worked we would never had this epidemic, let alone the worst one ever. Yet here we are….” – German Lopez, Vox
“In the middle of us continuing mass incarceration and a tough war on drugs we are having the worst drug epidemic in US history. If these policies actually worked we would never had this epidemic, let alone the worst one ever. Yet here we are….” – German Lopez, Vox
Interventions to enhance testing, linkage to care and treatment uptake for hepatitis C virus infection among people who inject drugs: A systematic review
The burden of hepatitis C virus (HCV) infection is escalating among people who inject drugs (PWID), yet testing and treatment remains suboptimal. The aim of this systematic review was to evaluate the effectiveness of interventions to enhance HCV testing, linkage to care, and treatment uptake among PWID.
The burden of hepatitis C virus (HCV) infection is escalating among people who inject drugs (PWID), yet testing and treatment remains suboptimal. The aim of this systematic review was to evaluate the effectiveness of interventions to enhance HCV testing, linkage to care, and treatment uptake among PWID.
Elimination of hepatitis C virus infection among PWID: The beginning of a new era of interferon-free DAA therapy
This special issue published in the International Journal of Drug Policy includes original research articles, systematic and expert reviews, and commentaries focused on the “Elimination of hepatitis C virus infection among PWID: the beginning of a new era of interferon-free DAA therapy”.
This special issue published in the International Journal of Drug Policy includes original research articles, systematic and expert reviews, and commentaries focused on the “Elimination of hepatitis C virus infection among PWID: the beginning of a new era of interferon-free DAA therapy”.
